Pasar al contenido principal

MICROBIOMA INTESTINAL EN LA EVALUACION DE RIESGOS DE ADITIVOS ALIMENTARIOS SULFONADOS: REVELANDO LOS MECANISMOS DE INTERACCION

PID2022-136874OB-C33

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The anticancer activity of bovine lactoferrin is reduced by deglycosylation and it follows a different pathway in cervix and colon cancer cells

  • Ramírez Sánchez, Diana A.
  • Canizalez Román, Adrián
  • León Sicairos, Nidia
  • Pérez Martínez, Gaspar
Bovine lactoferrin (bLF) is a glycosylated protein with purported beneficial properties. The aim of this work was to determine the role of bLF glycosylation in the adhesion, internalization, and growth inhibition of cancer cells. The viability of cervix (HeLa) and colon (Caco-2) cancer cells (MTT assay and epifluorescence microscopy) was inhibited by bLF, while deglycosylated bLF (bLFdeg) had no effect. Adhesion to cell surfaces was quantified by immunofluorescence assay and showed that bLF was able to bind more efficiently to both cell lines than bLFdeg. Microscopic observations indicated that bLF glycosylation favored bLF binding to epithelial cells and that it was endocytosed through caveolin-1-mediated internalization. In addition, the mechanism of action of bLF on cancer cell proliferation was investigated by determining the amount of phosphorylated intermediates of signaling pathways such as epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase (ERK) and protein kinase B (known as Akt). Chemoluminescence immunoassay of phosphorylated intermediates showed that bLF inhibited Akt phosphorylation, consistent with its growth inhibiting activity. This assay also indicated that the bLF receptor/signaling pathways may be different in the two cell lines, Caco-2 and HeLa. This work confirmed the effect of glycosylated bLF in inhibiting cancer cell growth and that glycosylation is required for optimal surface adhesion, internalization, and inhibition of the ERK/Akt pathway of cell proliferation through glycosylated cell surface receptors., The project was supported by Spanish Ministry of Science and Innovation, grant RTI2018-097982-B-I00, Grant PID2022-136874OB-C33 funded by MCIN/AEI/doi.org/10.13039/501100011033, Severo Ochoa Accreditation CEX2021-001189-S and Generalitat Valenciana grant Prometeo CIPROM_2021_082. Ramirez-Sánchez, D.A. was recipient of a PhD scholarship from CONACyT MEXICO (Ref. 291250) and she was supported by a grant of the Fundación Carolina-SEGIB, Spain., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicles from L. paracasei improve neuroinflammation, GABA neurotransmission and motor incoordination in hyperammonemic rats

  • Arenas, Yaiza M.
  • Pérez Martínez, Gaspar
  • Montoliu, Carmina
  • Llansola, Marta
  • Felipo, Vicente
Patients with liver cirrhosis may show minimal hepatic encephalopathy (MHE) with motor incoordination and cognitive impairment that reduce life quality and span. Motor incoordination is due to neuroinflammation and enhanced GABAergic neurotransmission in cerebellum. Recent reports support that probiotics, including L. casei, may improve cognitive function in different pathologies and MHE in cirrhotic patients. Extracellular vesicles (EV) are small cell-derived membrane vesicles that carry bioactive molecules released from cells, including bacteria. We hypothesized that EV from Lacticaseibacillus paracasei (LC-EV) could improve neuroinflammation, GABAergic neurotransmission and motor function in MHE. We show that LC-EV treatment reverses glial activation and neuroinflammation in cerebellum and restore motor coordination in hyperammonemic rats. Moreover, ex vivo treatment of cerebellar slices from hyperammonemic rats with LC-EV also reverses glial activation and neuroinflammation, and the enhancement of the TNFR1-S1PR2-BDNF-TrkB and TNFR1-TrkB-pAKT-NFκB-glutaminase-GAT3 pathways and of GABAergic neurotransmission. The results reported support that LC-EV may be used as a therapeutic tool to improve motor incoordination in patients with MHE., This work was supported in part by Ministerio de Ciencia e Innovación Spain (PID2020-113388RB-I00; AEI/https://doi.org/10.13039/501100011033); Consellería Educación, Universidades y Ocupación, Generalitat Valenciana (CIPROM 2021/082); European Regional Development Funds / ERDF (PID2020-113388RB-I00 and CIPROM 2021/082); Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). Instituto de Salud Carlos III (PI23/00062), co-funded ERDF funds. YMA has a Margaritas Salas contract from University of Valencia (MS21-120). This work was also supported by Spanish Ministry of Science and Innovation Grant PID2022-136874OB-C33 funded by MCIN/AEI/doi https://doi.org/10.13039/501100011033, Severo Ochoa Accreditation CEX2021-001189-S., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

  • Giner Pérez, Lola
  • Gallego, Juan-José
  • Gimènez Garzó, Carla
  • Batallas, Daniela
  • Jarquín Díaz, Víctor H.
  • Casanova Ferrer, Franc
  • Fiorillo, Alessandra
  • Urios, Amparo
  • Martínez-Medina, Jennifer N
  • López-Gramaje, Adrià
  • Arenas, Yaiza M.
  • Escudero García, Desamparados
  • Benlloch, Salvador
  • Salvador, Alicia
  • Felipo, Vicente
  • Forslund-Startceva, Sofia K.
  • Pérez Martínez, Gaspar
  • Montoliu, Carmina
Although it is well established that liver disease is associated with alterations in the gut microbiome (GM), the mechanisms linking these microbial changes to the progression of liver disease-and more critically, to its related cognitive impairment-remain poorly understood. Therefore, to define biomarkers for the early and advanced phases of these conditions, it is necessary to gain insight into changes in the GM throughout the evolution of the disease, particularly regarding the early onset of cognitive decline., The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by Agencia Valenciana de Innovación, Generalitat Valenciana (Consolidacio Cadena Valor); Generalitat Valenciana (CIPROM2021/082, co-funded ERDF funds; CIACIF/2022/444); Instituto de Salud Carlos III (PI23/00062), co-funded ERDF funds; ayuda PID2022-136874OB-C33 financiada por MCIN/AEI/10.13039/501100011033 y por la Unión Europea NextGenerationEU/PRTR; F. Sarabia Donation (PRV00225); Universidad de Valencia, Ayudas para Acciones Especiales (UV-INV_AE-2633839); Ministerio de Universidades, Margarita Salas grant (MS21-120); Ministerio de Ciencia e Innovación (FPU2022/02975 and PID2020-119406GB-I00/AEI/10.13039/501100011033). INCLIVA/Universidad de Valencia, Programa de Proyectos de Investigación Traslacional VLC-Bioclinic (PI-2023-001). Action was co-financed by the European Union through the Operational Program of the European Regional Development Fund (FEDER) of the Comunidad Valenciana 2014–2020. Finally, we acknowledge the award of the Spanish government MCIU/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIU/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacterial extracellular vesicles in the brain: Pathological effects and therapeutic possibilities

  • Arenas, Yaiza M.
  • Izquierdo-Altarejos, Paula
  • Pérez Martínez, Gaspar
  • Felipo, Vicente
  • Llansola, Marta
The mechanisms leading to neurological and neurodegenerative diseases are not completely known, and new, more effective, therapeutic treatments are necessary for most neurological pathologies. The treatment of neurological and neurodegenerative diseases is complicated due to the blood-brain barrier, which makes it difficult for drugs to access the brain areas in which they must act to improve the pathology. A tool that can help to overcome this difficulty is the use of extracellular vesicles, which can easily cross the blood-brain barrier. The extracellular vesicles are considered a main way of communication between the brain and the rest of the body, with important implications for the physiopathology and therapy of neurological diseases. In recent years, the involvement of microbiota in many neurological pathologies, as well as its possible therapeutic role, has also become evident. A key mediator in the pathologic and beneficial effects of microbiota seems to be the bacterial extracellular vesicles. There is an important communication between the brain and the intestinal microbiota (the gut-brain axis), by which the microbiota influences brain function, impacts on mental health, and plays a role in different neurological and neurodegenerative diseases. The identification of the mechanisms involved in this gut-brain axis is essential to understanding the mechanisms of neurological pathologies and to developing more effective treatments for these diseases. Bacterial extracellular vesicles would play a relevant role in these processes. This review compiles the recent information and evidence on the role of bacterial extracellular vesicles in brain pathologies and on the therapeutic utility of bacterial extracellular vesicles in neurological and neurodegenerative diseases. One advantage of bacterial extracellular vesicles compared to extracellular vesicles derived from other cell types, such as stem cells, is that bacterial extracellular vesicles are generally easier to produce and modify. Bacterial extracellular vesicles may be easily modified to target a specific pathology and/or to enhance its therapeutic efficacy. Although the studies are still scarce, they open a wide field of possibilities for future studies, which will lead to a deeper understanding of the role of microbiota and bacterial extracellular vesicles in neurological pathologies and the underlying mechanisms, as well as to the development of new treatments based on the use of bacterial extracellular vesicles in neurological diseases., This work was funded by the Ministerio de Ciencia e Innovación Spain (PID2020-113388RB-I00; AEI/10.13039/501100011033), Consellería de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIPROM/2021/082) and co-funded with European Regional Development Funds (ERDF) (PID2020-113388RB-I00; and CIPROM/2021/082) and PID2022-136874OB-C33 from MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/ PRTR (to VF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hyperammonemia reduces the populations of beneficial lactobacilli and bifidobacteria, disrupting the metabolic balance of the gut microbiome in rats

  • Giner-Pérez, Lola
  • Felipo, Vicente
  • Izquierdo-Altarejos, Paula
  • Llansola, Marta
  • Pérez Martínez, Gaspar
The gut microbiome (GM) plays a critical role in metabolic and neurological health and is implicated in hepatic encephalopathy (HE). Chronic hyperammonemia (HA), a major contributor to cognitive and motor impairment in HE, may influence GM structure and function, yet its specific efects in GM remain unclear. Methods: Here, it was investigated how chronic HA alters the GM using a rat model fed an ammonia-enriched diet for 4 weeks. Fecal microbiota profiles obtained by 16S rRNA gene sequencing revealed marked taxonomic shifts in HA rats, with beta-diversity showing clear separation from controls. Results: Genera within the Lachnospiraceae family and Alistipes genus were enriched in HA rats, while lactic acid-producing and xylanolytic Firmicutes were reduced. Network analysis identified Alistipes as a central node in the HA microbiome. Predicted metabolic functions were significantly altered, showing negative associations between HA and pathways related to the pyruvate dehydrogenase complex, sucrose and urea degradation, and 4-aminobutyrate (GABA) degradation. Consistent with these predictions, fecal short-chain fatty acid (SCFA) analysis revealed reduced acetic and butyric acid, alongside increased valeric and isobutyric acid levels. The predicted GABA levels increasement by GM would activate GABA receptors in immune cells and would also contribute to peripheral inflammation and, eventually, neuroinflammation. Conclusions: Together, these findings demonstrate that chronic HA reshapes GM composition, disrupts key metabolic pathways, and alters SCFA profiles, providing mechanistic insight into how HA- associated dysbiosis may contribute to the metabolic, immune, and neurological dysfunction characteristic of HE., The author(s) declared that financial support was received for this work and/or its publication. This work was supported by Generalitat Valenciana (CIPROM2021/082); ayuda PID2022-136874OB-C33 financiada por MCIN/AEI/10.13039/501100011033 y por la Unión Europea NextGenerationEU/PRTR; Ministerio de Ciencia e Innovación (FPU2022/02975); JDC2023-050525-I, funded by MCIU/AEI/10.13039/501100011033 and FSE+., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed